Asmaa Abdelaziz MohamedMarwa M KamilFiras Aziz RahiNoor Zuhair Kbah
Recent breakthroughs in pharmaceutical delivery methods employing a range of carriers have radically transformed modern diagnostic and therapeutic practices. Mesoporous silica nanoparticles (MSNs) were created due to the demand for substances with superior thermal and chemical capabilities. These ordered porous substances have generated a lot of interest as carriers due to their distinct advantages over the competition. They may be made economically using a simple process. Moreover, the shape, pore size, and particle size may all be changed by modifying the synthesis's conditions. Investigations on MSNs as drug carriers have reportedly accelerated in recent years, highlighting the potential benefits of such a drug delivery approach. MSNs have proven to be effective transporters for anticancer, anti-inflammatory, and neurological medications. This review discusses the origin, synthesis, and most recent applications of MSN
Asmaa Abdelaziz MohamedMarwa M KamilFiras Aziz RahiNoor Zuhair Kbah
Juan L. Vivero‐EscotoBrian G. TrewynVictor S.-Y. Lin
Mladenović, MinjaMundžić, MirjanaPavlović, AleksandraKnežević, Nikola